• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    ProDx Health’s Receives FDA Warning Letter

    FDA

    Central Coast Multispecialty’s Receives FDA Warning Letter

    FDA

    Mark S Dacey’s Receives FDA Warning Letter

    FDA

    Bio Medical Manufacturing’s Receives FDA Warning Letter

    FDA

    Signature Formulations’ Receives FDA Warning Letter

    FDA

    Boothwyn Pharmacy’s Receives FDA Warning Letter

    FDA

    Conceive Fertility Center’s Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of February 4, 2026

    FDA

    Panacea Biotec Limited Fails EDQM Inspection

    EMA

    HTO Nevada’s Receives FDA Warning Letter

    FDA

    Cohance Lifesciences’ Receives FDA Warning Letter

    FDA

    FD A Issues Form 483 toUS Specialty Formulations

    FDA

    Hangzhou Yiqi Biotechnology is on FDA Import Alert List

    FDA

    Hebei Shengxue Dacheng Pharmaceutical Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to JKR Pharmacy Ventures

    FDA

    FDA Issues Form 483 to InnoStar Bio-Tech Nantong

    FDA

    Enforcement Report - Week of January 28, 2026

    FDA

    FDA Issues Form 483 to Empower Clinic Services dba Empower Pharma

    FDA

    Fulijaya Manufacturing SDN BHD’s Receives FDA Warning Letter

    FDA

    Center For Immunology’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Denver Solutions

    FDA

    Flowchem Pharma is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Joinn Laboratories Co.

    FDA

    FDA Issues Form 483 to Nubratori

    FDA

    FDA Issues Form 483 to Pine Pharmaceuticals

    FDA

    FDA Issues Form 483 to Petscript

    FDA

    FDA Issues Form 483 to Asahi Kasei Finechem Co.

    FDA

    Enforcement Report - Week of January 21, 2026

    FDA

    FDA Issues Form 483 to Sato Pharmaceutical Co.

    FDA

    FDA Issues Form 483 to Lupin Limited

    FDA

    Germaphobix’s Receives FDA Warning Letter

    FDA

    Genetrace’s Receives FDA Warning Letter

    FDA

    ProDx Health’s Receives FDA Warning Letter

    FDA

    Genovate’s Receives FDA Warning Letter

    FDA

    Integrity Partners Group’s Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of January 14, 2026

    FDA

    Purushothaman Damodara Kumaran’s Receives FDA Warning Letter

    FDA

    Chemspec Chemicals’ Receives FDA Warning Letter

    FDA

    Winder’s Receives FDA Warning Letter

    FDA

    Anthony Trinh Issues Nationwide Recall of Silintan Capsules

    FDA

    Modern Recalls “Modern Warrior Ready” Dietary Supplement

    FDA

    Asanuma Corporation is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Pure Indulgence Aesthetics

    FDA

    Antaria Pty. Ltd. is on FDA Import Alert List

    FDA

    Cosmetic Manufacturers (Aust) Pty. is on FDA Import Alert List

    FDA

    Veganic SKN Limited is on FDA Import Alert List

    FDA

    PLZ Corp. is on FDA Import Alert List

    FDA

    Enforcement Report - Week of January 7, 2026

    FDA

    Tower’s Receives FDA Warning Letter

    FDA

    LiquidCapsule Manufacturing’s Receives FDA Warning Letter

    FDA

    Absolutely Natural’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Dr. Reddy

    FDA

    FDA Issues Form 483 To Lonza Guangzhou Pharmaceutical

    FDA

    Enforcement Report - Week of December 31, 2025

    FDA

    Unipack’s Receives FDA Warning Letter

    FDA

    Devalingam Mahalingam’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Pharmathen

    FDA

    Gold Star Issues Recall of Certain FDA-Regulated Products

    FDA

    Enforcement Report - Week of December 24, 2025

    FDA

    Guangdong Renhe Guozhuang Biotech’s Receives FDA Warning Letter

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.